Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Aura Biosciences Inc (AURA)

Aura Biosciences Inc (AURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aura Biosciences Inc 80 GUEST STREET BOSTON MA 01235 USA

www.aurabiosciences.com Employees: 89 P: 617-500-8864

Description:

Aura Biosciences Inc. is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system. The company's lead product candidate includes AU-011. Aura Biosciences Inc. is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 409,598
Enterprise Value, $K 368,518
Shares Outstanding, K 49,951
Annual Sales, $ 0 K
Annual Net Income, $ -76,410 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -21,040 K
EBIT, $ -93,080 K
EBITDA, $ -91,780 K
60-Month Beta 0.26
% of Insider Shareholders 5.40%
% of Institutional Shareholders 96.75%
Float, K 47,254
% Float 94.60%
Short Volume Ratio 0.80

Growth:

1-Year Return -3.07%
3-Year Return -48.88%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.42 on 11/12/24
Next Earnings Date 11/14/24
Earnings Per Share ttm -1.73
EPS Growth vs. Prev Qtr -2.44%
EPS Growth vs. Prev Year 12.50%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

AURA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -41.57%
Return-on-Assets % -36.43%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.30
Book Value/Share 3.52
Interest Coverage -2.86
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar